[e-drug] Re: Essential Drug Lists in Central Asian Republics

E-drug: Re: Essential Drug Lists in Central Asian Republics
-------------------------------------------------------------------------

A student, Aziz Jafarov, at BUSPH has just completed a study of
the Essential Drug Lists in four Central Asian Republics. I have
posted the paper and the Annexes on the web at
http://dcc2.bumc.bu.edu/richardl/RPM+_Project/Aziz.htm

The abstract reads:
Azizkhon Jafarov. Selection of essential drug lists in Central Asian
Republics. Comparison and discrepancies. May 2002.

The concept of Essential Drug Lists (EDL) is new for the Central
Asian Republics (CARs) since there was no EDL in the Soviet Union
and the Soviet System considered all registered drugs as essential.
In the mid 90th, the World Health Organization (WHO) introduced
the EDL concept to the CARs as a tool to improve pharmaceutical
supply. By now the countries have developed national essential
drug lists and even revised them.

Although the health indicators and economic situation is very similar
among the CARs, the EDLs of Kazakhstan, Kyrgyzstan, Tajikistan
and Uzbekistan vary considerably. At least some of the above
countries require revision of the selected drugs and the selection
process needs to move from experienced-based medicine towards
evidence-based medicine.

This paper compares the current EDLs of four former Soviet CARs,
Kazakhstan, Kyrgyzstan, Tajikistan and Uzbekistan, taking the 1999
WHO Model list as standard. The paper analyzes the national lists
and highlights the main areas of disparities by looking at the drugs
selected by each of the four countries as essential. In addition, the
paper discusses the value of the ED Concept in relation to CARs.

This paper is designed to help public agencies such as government
and international organizations involved in the process of creating
and revising national drug lists. The paper provides specific
recommendations for the way forward in the next two to three
years.

If you are unable to download this paper please contact me and I
will send you the file.

Richard Laing
Associate Professor of International Health
Boston University School of Public Health
715 Albany St, T4W, Boston MA 02118 USA
Tel 617 414-1444 Fax 617 638-4476
E-mail richardl@bu.edu

--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html